- Home
- INHD vs EVAX Comparison
INHD vs EVAX Comparison
Compare INHD & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- EVAX
- Stock Information
- Founded
- INHD 2019
- EVAX 2008
- Country
- INHD United States
- EVAX Denmark
- Employees
- INHD N/A
- EVAX N/A
- Industry
- INHD
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- INHD
- EVAX Health Care
- Exchange
- INHD Nasdaq
- EVAX Nasdaq
- Market Cap
- INHD 12.1M
- EVAX 14.3M
- IPO Year
- INHD 2023
- EVAX 2021
- Fundamental
- Price
- INHD $4.54
- EVAX $1.65
- Analyst Decision
- INHD
- EVAX Strong Buy
- Analyst Count
- INHD 0
- EVAX 2
- Target Price
- INHD N/A
- EVAX $11.00
- AVG Volume (30 Days)
- INHD 147.8K
- EVAX 27.9K
- Earning Date
- INHD 11-26-2024
- EVAX 10-31-2024
- Dividend Yield
- INHD N/A
- EVAX N/A
- EPS Growth
- INHD N/A
- EVAX N/A
- EPS
- INHD N/A
- EVAX N/A
- Revenue
- INHD $693,570.00
- EVAX $3,295,000.00
- Revenue This Year
- INHD N/A
- EVAX $4,845.21
- Revenue Next Year
- INHD N/A
- EVAX $30.30
- P/E Ratio
- INHD N/A
- EVAX N/A
- Revenue Growth
- INHD N/A
- EVAX N/A
- 52 Week Low
- INHD $3.00
- EVAX $1.59
- 52 Week High
- INHD $192.10
- EVAX $13.61
- Technical
- Relative Strength Index (RSI)
- INHD 47.86
- EVAX 20.33
- Support Level
- INHD $3.00
- EVAX $1.59
- Resistance Level
- INHD $8.99
- EVAX $2.63
- Average True Range (ATR)
- INHD 1.00
- EVAX 0.22
- MACD
- INHD 0.05
- EVAX -0.10
- Stochastic Oscillator
- INHD 25.72
- EVAX 3.97
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About EVAX Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.